Eisai EMEA
Dr. Steewen Krohne is a skilled professional in the field of medical affairs, currently serving as Manager of Medical Affairs and Medical Scientific Liaison Manager for Oncology at Eisai EMEA since April 2019. Prior experience includes a PhD focused on virology from the Heinrich Pette Institute, where research involved adenoviruses, tumor virology, and immunology. Additional experience encompasses a master’s program at Helmholtz Institute, concentrating on antibody-based immunotoxins, as well as an internship at the Fraunhofer Institute, where topics included smart polymers and data analysis. Dr. Krohne holds a Bachelor of Science in Biology from FAU Erlangen-Nürnberg and a Master of Science in Cell- and Molecular Biology from RWTH Aachen University.
This person is not in any offices
Eisai EMEA
3 followers
At Eisai, everything we do is dedicated to giving our first thought to patients and their families through our human health care (hhc) philosophy. We are the European hub of Tokyo-based Eisai Co. Ltd., forming part of a multinational team working across a global network of R&D facilities, manufacturing sites and marketing subsidiaries. Our collective passion and dedication to patient care is the driving force behind our efforts to discover and develop innovative medicines in a variety of therapeutic areas in which a high unmet medical need remains, including oncology and neurology. Our mission is clear; we strive to make a significant long-lasting contribution to society in an ethical, compliant and sustainable way by embodying our hhc philosophy in everything we do. For more information about Eisai in the EMEA region please visit www.eisai.eu Our community guidelines can be found here: https://www.eisai.eu/wp-content/uploads/Community-guidelines-v1.0.pdf For more information about how Eisai processes your data, please refer to our privacy policy here: https://www.eisai.eu/privacy-policy/ --- November 2023 | EMEA-NON-23-00180